SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
383<i>2003 AACR-NCI-EORTC epothilone abstracts:</i> A248 Phase 1 dose Biomaven-11/18/2003
382correct! (eom)scaram(o)uche-11/14/2003
381Thank you. And also ceases to be recognized by enzymes that previously did markquidditch-11/14/2003
380I don't know, don't remember if it was on the bid or ask. It's whenscaram(o)uche-11/14/2003
379On the asked? Rick, what does phosphorylation mean?quidditch-11/14/2003
378three 25-50K blocks. sitting, not doing much, down a nickel. volume at today&#scaram(o)uche-11/14/2003
377Wellington files for ~10% 13g.keokalani'nui-11/10/2003
376>>Clin Cancer Res. 2003 Oct 15;9(13):4961-4971. Hormone-Refractory Breatuck-10/29/2003
375Blood. 2003 Oct 23 [Epub ahead of print]. Geldanamycin and Herbimycin A inducscaram(o)uche-10/26/2003
374[17AAG -- PK & PD in mice with human tumor xenografts] >>J Pharmacokituck-10/24/2003
373Kosan Reports Third Quarter and Nine Month Financial Results Thursday October 23nigel bates-10/23/2003
372I looked for a KOSN CC, but I guess they are too busy selling...mopgcw-10/19/2003
371This is one element that I love about Kosan.... any success, and they'll scaram(o)uche-10/19/2003
370chemie.de Designed antitumor agent with a highly promising pharmacological profscaram(o)uche-10/16/2003
369[17-AAG: Clinical development] Don't think this has been posted . . .tuck-10/15/2003
368more of the same, big chunk variety...... FILED: 10/10/2003 12:00 AM FILER: KANscaram(o)uche-10/15/2003
367<HIF> I follow HIF very closely because of an investment in a private comBiomaven-10/10/2003
366"helps when you've found those who would be your competitor." OK,tuck-10/10/2003
365<i> helps when you've found those who would be your competitor.</i&Biomaven-10/9/2003
364It always helps, when you've found those who would be your competitor. :-scaram(o)uche-10/9/2003
363The tox didn't sound too bad at the Phase I abstract at ASCO - but of courseBiomaven-10/9/2003
362Thank you! EOM.keokalani'nui-10/9/2003
361emphasis mine...... Curr Cancer Drug Targets. 2003 Oct;3(5):371-6. Developmentscaram(o)uche-10/9/2003
360[17-AAG and angiogenesis inhibitors] >>Published online before print Octotuck-10/3/2003
359just incremental information .... and in some cases maybe off topic ... Our sciJohn McCarthy-9/26/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News